MARKET

OCS

OCS

Oculis Holding
NASDAQ
27.46
+0.09
+0.33%
After Hours: 27.46 0 0.00% 16:10 04/17 EDT
OPEN
27.48
PREV CLOSE
27.37
HIGH
27.71
LOW
26.88
VOLUME
367.41K
TURNOVER
--
52 WEEK HIGH
30.68
52 WEEK LOW
16.00
MARKET CAP
1.59B
P/E (TTM)
-11.5035
1D
5D
1M
3M
1Y
5Y
1D
Oculis Holding: Needham Conference Visibility Reinforces Buy Rating and Upside Potential
TipRanks · 2d ago
Weekly Report: what happened at OCS last week (0406-0410)?
Weekly Report · 4d ago
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
Barchart · 04/08 15:05
Oculis to Participate in Upcoming Investor Conferences
Barchart · 04/07 03:00
Weekly Report: what happened at OCS last week (0330-0403)?
Weekly Report · 04/06 10:25
Oculis Receives European Medicines Agency PRIME Designation For Privosegtor In Optic Neuritis, Accelerating PIONEER Registrational Program Across Three Global Trials
Benzinga · 03/31 08:10
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
Barchart · 03/31 03:00
Weekly Report: what happened at OCS last week (0323-0327)?
Weekly Report · 03/30 10:25
More
About OCS
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Webull offers Oculis Holding AG stock information, including NASDAQ: OCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCS stock methods without spending real money on the virtual paper trading platform.